Last updated 2026-07-20
- Acquired by Illumina, Dec 2021
- Raised $6M Series A led by OTV, Jan 2019
- Raised $19k grant, Sep 2018
Total raised
$6.0M
Last: Undisclosed Round 2019-02
Stage
Acquired
Founded
2016
Headcount
12
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Emedgene provides the world's first completely automated genetic interpretation platform, leveraging advanced AI to scale genetic interpretation and discovery. Their solution aims to improve dry lab efficiency for clinical labs, significantly reducing the time spent on interpretation and research. The company's platform utilizes an AI engine that performs genomics research through millions of data points from patient cases, databases, and the most recent genomic publications, enabling healthcare professionals to provide personalized care to more patients through higher resolution rates and significantly improved yield.
Funding history · 3 rounds · $6.0M total
2019-01
A Round
$6.0M
★ OTVMindset VenturesRIO Ventures Holdings
2018-09
Grant
$19K
2017-07
Seed
Undisclosed
★ PLUS Ventures
Headcount over time
From 5 (2016-06) to 35 (2026-07) · +30 (+600%) · 17 points · source: Finder history + radar grounding
Q&A
- What is Emedgene's primary business?
- Emedgene is a genomics intelligence platform that uses natural language processing and machine learning to interpret genetic publications and pinpoint pathogenic variants for clinical decisions.
- When was Emedgene founded?
- Emedgene was founded in April 2015.
- What is the current status of Emedgene?
- Emedgene was acquired by Illumina in December 2021 and is currently inactive.
- How much funding has Emedgene raised in total?
- Emedgene has raised a total of $6,019,000 across its funding rounds.
- When was Emedgene's last funding round and who were the lead investors?
- Emedgene's last funding round occurred in February 2019, with OTV as a lead investor.
- Who are the co-founders of Emedgene?
- The co-founders of Emedgene are Einat Metzer (CEO), Shay Tzur (CSO), and Niv Mizrahi (CTO).
- What technologies does Emedgene utilize in its platform?
- Emedgene utilizes Artificial Intelligence, Machine Learning, and Natural Language Processing in its platform.
Team · 6
Eran Halperin
Founder · Co-Founder
Dr. Nir Barzilai
Founder · Co-Founder & Chief Medical Officer
Einat Metzer
Founder · Co-Founder & CEO
Niv Mizrahi
Founder · Co-Founder & CTO
Shay Tzur
Founder · Co-Founder & CSO
Ofir Farchy
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
BiologicalsGenesArtificial IntelligenceMachine LearningNatural Language Processing
Target customers
EducationHigher EducationHealthcare & Life SciencesHealthcareLaboratoriesProviders
Business model
B2B
Highlights
Verified
Tags
big-datagenomicsmedical-technologiesartificial-intelligencehealthcare-providersprecision-medicinegeneticsmachine-learninghospitalslaboratoriesdoctorsdeep-learningnatural-language-processingdiagnosticsdigital-healthcaredata-analyticspersonalized-medicinetreatmentsgenetic-disordersdecision-supportsaasacademia
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | www.emedgene.com |
|---|---|
| linkedin.com/company/10391591 | |
| facebook.com/emedgene | |
| YouTube | youtube.com/channel/UCUSPMpmk8IDvztYqMsZIvOA |
Identifiers & details
| Legal name | Emedgene Technologies Ltd. |
|---|---|
| Founded | 2016 |
| Employees (exact) | 12 |
| Offices | Palo Alto |
| Status reason | Acquired (Inactive) by Illumina on Dec 2021 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Illumina 2021-12
Radar intelligence
Publications (Crossref)
| Works | 6 |
|---|
GitHub
| Top repos | vcfio, cnv2vcf, fs_basespace, igv.js, basespace-python-sdk-v2 |
|---|
Web history (Wayback)
| Domain | emedgene.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515242147 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-04-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — charge (1), annual_report (1), people (1) |
| Registered address | אלון יגאל 114 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-30 | סילוק שעבוד |
| 2026-06-28 | דו~ח שנתי |
| 2026-07-07 | עדכון בעלי תפקידים |